Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP001153

Drug Information
NameTrimipramine    
Synonyms5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N,N,beta-trimethyl-, (+)- (9CI); AB00053646; BPBio1_000739; Trimipramine (USAN/INN); 1-(3-Dimethylamino-2-methylpropyl)-4,5-dihydro-2,3:6,7-dibenzazepine; Trimipraminum; 10,11 Dihydro-N,N,beta-trimethyl-5H-dibenz(b,f)azepine-5-propanamine; 10633 RP; Surmontyl; 5H-Dibenz(b,f)azepine, 5-(3-(dimethylamino)-2-methylpropyl)-10,11-dihydro-, (-)-; Prestwick3_000806; 5-(3-(Dimethylamino)-2-methylpropyl)-10,11-dihydro-5H-dibenz(b,f)azepine; KBioGR_001118; Spectrum3_001151; UNII-6S082C9NDT; 5H-Dibenz(b,f)azepine, 10,11-dihydro-5-(3-(dimethylamino)-2-methylpropyl)-; (+)-Trimipramine; trimipramine; KBio2_001902; Prestwick2_000806; NCGC00016013-03; LS-60464; Spectrum5_001052; 5H-Dibenz(b,f)azepine, 5-(3-(dimethylamino)-2-methylpropyl)-; ( )-Trimipramine; 5-(gamma-Dimethylamino-beta-methylpropyl)-10,11-dihydro-5H-dibenzo(b,f)azepine; KBio3_002201; Trimipramina; 5-(gamma-dimethylamino-beta-methylpropyl)-10,11-dihydro-5H-dibenzo[b,f]azepine; 5-[3-(dimethylamino)-2-methylpropyl]-10,11-dihydro-5H-dibenz[b,f]azepine; Trimipramine [USAN:INN:BAN]; CHEMBL644; BSPBio_000671; 5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N,N,beta-trimethyl-; Trimeprimine; DivK1c_000093; InChI=1/C20H26N2/c1-16(14-21(2)3)15-22-19-10-6-4-8-17(19)12-13-18-9-5-7-11-20(18)22/h4-11,16H,12-15H2,1-3H; 5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N,N,beta-trimethyl-, (-)- (9CI); 5H-Dibenz(b,f)azepine, 5-(3-(dimethylamino)-2-methylpropyl)-10,11-dihydro-, (+)-; 5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N,N,beta-trimethyl-, (+)-; SPBio_002592; LS-60463; 5H-Dibenz(b,f)azepine, 5-(3-(dimethylamino)-2-methylpropyl)-10,11-dihydro-; (-)-Trimipramine; L000969; KBioSS_001902; Lopac0_001156; Trimeproprimine; 3564-75-8; 5H-Dibenz(b,f)azepine, 10,11-dihydro-5-(3-(dimethylamino)-2-methylpropyl)-, (-)-; 521-78-8 (maleate (1:1)); Prestwick0_000806; 3564-66-7; Sapilent; Trimeproprimin; Trimipramine, (-)-Isomer; LS-60465; 7162 RP; 5-20-08-00099 (Beilstein Handbook Reference); CHEBI:9738; Surmontil; Prestwick1_000806; BSPBio_002701; Trimipraminum [INN-Latin]; Spectrum_001422; Trimipramina [INN-Spanish]; BRD-A19195498-050-05-9; AC-15969; Spectrum2_001530; Spectrum4_000759; Stangyl; 3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N,2-trimethylpropan-1-amine; 3589-21-7 (mono-hydrochloride); 5H-Dibenz[b,f]azepine-5-propanamine, 10,11-dihydro-N,N,.beta.-trimethyl-; NINDS_000093; 2'-Metil-3'-dimetilamino-propil-5-iminodibenzile; Trimeprimina [Italian]; KBio2_004470; IL-6001; RP-7162; D00394; SPBio_001320; EINECS 212-008-3; 5H-Dibenz(b,f)azepine, 10,11-dihydro-5-(3-(dimethylamino)-2-methylpropyl)-, (+)-; 10,11-dihydro-N,N,beta-trimethyl-5H-dibenz[b,f]azepine-5-propanamine; BRN 1321466; Trimeprimina; 25332-13-2 (mesylate); CID5584; KBio2_007038; DB00726; IDI1_000093; MolPort-005-935-550; Oprea1_375679; 739-71-9; NCGC00162356-01; 3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N,2-trimethylpropan-1-amine; FI 6120; 2'-Metil-3'-dimetilamino-propil-5-iminodibenzile [Italian]; KBio1_000093; AC1L1KO8; 10645 RP; IL 6001; 10,11-Dihydro-5-(3-dimethylamino-2-methylpropyl)-5H-dibenz(b,f)azepine; beta-Methylimipramine    
Trade NameStangyl; Surmontil; Rhotrimine    
IndicationDepressionApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassAntidepressants    
CAS NumberCAS 739-71-9
FormularC20H26N2    
PubChem Compound IDCID 5584.    
PubChem Substance IDSID 156272.    
ChEBI9738;    
SuperDrug ATC IDN06AA06;    
SuperDrug CAS ID000739719;    
TargetNorepinephrine reuptakeInhibitor[2]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 077361 To Reference
Ref 2Antidepressants suppress production of the Th1 cytokine interferon-gamma, independent of monoamine transporter blockade. Eur Neuropsychopharmacol. 2006 Oct;16(7):481-90. Epub 2006 Jan 4. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543